您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Cobicistat-d8
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Cobicistat-d8
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Cobicistat-d8图片
规格:98%
分子量:784.1
包装与价格:
包装价格(元)
500ug电议
1mg电议

产品介绍
A neuropeptide with diverse biological activities
货号:ajcx22118
CAS:N/A
分子式:C40H45D8N7O5S2
分子量:784.1
溶解度:DMF: 20 mg/ml,DMSO: 20 mg/ml,Ethanol: 10 mg/ml
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Cobicistat-d8is intended for use as an internal standard for the quantification of cobicistat by GC- or LC-MS. Cobicistat is an inhibitor of the cytochrome P450 (CYP) isomer CYP3A (IC50s = 30-285 nM for CYP3A metabolism of various HIV protease inhibitors).1It is selective for CYP3A over other CYP isomers (IC50= >25 μM for CYP1A2, 2C8, 2C9, and 2C19). Cobicistat does not inhibit HIV-1 protease (IC50= >30 μM) or affect HIV replication in MT-2 cells (EC50= >30 μM). Formulations containing cobicistat have been used to slow the metabolism of concomitantly administered protease inhibitors in the treatment of HIV.2


1.Xu, L., Liu, H., Murray, B.P., et al.Cobicistat (GS-9350): A potent and selective inhibitor of human CYP3A as a novel pharmacoenhancerACS Med. Chem. Lett.1(5)209-213(2010) 2.Harris, M., Ganase, B., Watson, B., et al.HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: A pharmacokinetic studyAIDS Res. Ther.14(1)59(2017)